Skip to main content

Table 2 Clinical characteristics of family 310. The patient number refers to the number in the pedigree in Figure 1.

From: PALB2 variants in hereditary and unselected Finnish Prostate cancer cases

Patient

Cancer

Histology

Age at diagnosis

Reason for diagnosis

First treatment

Primary PSA value

WHO grading

Gleason grading

TNM grading

IHC

6

Prostate

Adenocarcinoma

83

NA

NA

NA

NA

NA

NA

 

11

Prostate

Adenocarcinoma

68

Symptoms

Orchiectomy

NA

III

Na

T3NXMX

 

13

Stomach

Adenocarcinoma

70

Symptoms

Gastrectomy

NA

NA

Na

T4N0 M0

 

13

Skin

Carcinoma epidermoides

75

NA

Resection

NA

NA

Na

NA

 

13

Prostate

Adenocarcinoma

76

Elevated PSA

Orchiectomy

47

III

2+3 = 5

T2NXMX

 

15

Prostate

Adenocarcinoma

69

Elevated PSA

Brakytherapy

7.7

I

2+3 = 5

T1cNXMX

 

17

Breast

Ductal carcinoma

52

Screening mammography

Mammary resection

NA

I

Na

T1N0 M0

ER+, PR+

24

Breast

Ductal carcinoma

49

Mammography

Mammary resection

NA

I

Na

T1N0 M0

NA

  1. IHC = immunohistochemistry, NA = not available